Evidence review and causal analysis for the final evaluation of the national health strategy period: critical analysis of the topic: mental health: depression
ANTECEDENTES Y OBJETIVO
El análisis crítico de la Estrategia Nacional de Salud se enfocó en el objetivo de impacto de disminuir la prevalencia de discapacidad en personas con enfermedad mental.
Este informe presenta los resultados de la revisión exploratoria de evidencia para el tema de depresión, ...
Background Ayahuasca is a botanical hallucinogenic preparation traditionally used by indigenous populations of Northwestern Amazonian countries for ritual and therapeutic purposes. It is rich in β-carboline alkaloids and N,N-dimethyltryptamine (DMT). Preclinical, observational, and experimental stud...
Aberrant expression of microRNAs (miRNAs) has been shown to be involved in early observations of depression. The aim of this study was to determine if serum levels of miRNA-451a, miRNA-34a-5p, and miRNA-221-3p can serve as indicators of disease progression or therapeutic efficacy in depression. We collec...
Abstract Objective: To investigate the prevalence of anxiety and depression in patients admitted for acute coronary syndrome to a university hospital and to examine associations with use of psychotropic drugs. Methods: Ninety-one patients who had had an acute coronary event were enrolled on this cross-...
Introduction: Data have supported the influence of inflammation in the pathophysiology of depression and also the influence of depression in the development of a pro-inflammatory state. Major depressive disorder (MDD), the core depressive condition, has selective serotonin reuptake inhibitors (SSRI) as i...
Objetivo: Este estudo pretendeu conhecer aspectos dos utentes e consultas em que se fez pela primeira vez o diagnóstico de depressão. Métodos: Estudo observacional, transversal e descritivo. População obtida por aplicação de critérios de exclusão aos utentes que, em consulta durante 2011, tivera...
El emblemático ensayo clínico 329, financiado por Smith Kline Beecham (actualmente GlaxoSmith-Kline) y publicado en2001, permitió posicionar a la paroxetina como un tratamiento efectivo y seguro para la depresión mayor en adolescentes. En la presente editorial el autor describe los sucesos ocurridos ...